Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Get our best content in your email.

You are already a member! Please enter your password to sign in.

Stocks down in early trading, Allergan (AGN) rejects Valeant (T.VRX) takeover again

Canadian Press, The Canadian Press
0 Comments| June 10, 2014

TORONTO _ The Toronto stock market opened lower amid news that the board at Botox-maker Allergan Inc. (NYSE: AGNStock Forumhas unanimously rejected an improved takeover offer by Quebec-based Valeant Pharmaceuticals International Inc. (TSX: T.VRXStock Forum)

The S&P/TSX composite index fell 5.76 points to 14,865.45. The Canadian dollar was almost unchanged, up slightly by 0.02 of a cent to 91.70 cents US.

Allergan says Valeant's offer undervalues the California-based company and creates significant risks and uncertainties for its shareholders.

Earlier this month, with the backing of activist shareholder Bill Ackman, Valeant raised its stock-and-cash bid to about US$180 per share, valuing Allergan at more than US$54 billion.

Allergan repeated its claim that Valeant's has an unsustainable business model that relies on ``serial'' acquisitions and cost reductions, as opposed to revenue growth and operational excellence.

Meanwhile, Wall Street took back some gains at the open, as the Dow Jones industrials dropped seven points to 16,936.10, the Nasdaq fell 5.78 points to 4,330.46, while the S&P 500 index dipped 2.56 points to 1,948.71.


Rate this article
0 stars



Interested in these industries and sectors?

Receive investor kits and email updates from Stockhouse and directly from these companies.


Interested in these industries and sectors?

You are already a member! Please enter your password to sign in.


No comments yet. Be first to comment!

Leave a Message

You must be logged in to access this feature.